Type 2 diabetes with ASCVD — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Add an SGLT2 inhibitor or GLP-1 receptor agonist with cardiovascular benefit
Patients with type 2 diabetes and established ASCVD benefit from glucose-lowering agents with proven cardiovascular benefit when additional therapy is needed.
Reference: ADA Standards of Care in Diabetes 2026